These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1071 related articles for article (PubMed ID: 18509004)
21. Antiproliferative effect of sphingosylphosphorylcholine in thyroid FRO cancer cells mediated by cell cycle arrest in the G2/M phase. Afrasiabi E; Blom T; Balthasar S; Törnquist K Mol Cell Endocrinol; 2007 Aug; 274(1-2):43-52. PubMed ID: 17606321 [TBL] [Abstract][Full Text] [Related]
22. Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid. Gee MF; Tsuchida R; Eichler-Jonsson C; Das B; Baruchel S; Malkin D Oncogene; 2005 Dec; 24(54):8025-37. PubMed ID: 16116481 [TBL] [Abstract][Full Text] [Related]
23. Expression of VEGFR-2 on HaCaT cells is regulated by VEGF and plays an active role in mediating VEGF induced effects. Yang XH; Man XY; Cai SQ; Yao YG; Bu ZY; Zheng M Biochem Biophys Res Commun; 2006 Oct; 349(1):31-8. PubMed ID: 16930552 [TBL] [Abstract][Full Text] [Related]
24. Vascular endothelial growth factor receptor-1 regulates postnatal angiogenesis through inhibition of the excessive activation of Akt. Nishi J; Minamino T; Miyauchi H; Nojima A; Tateno K; Okada S; Orimo M; Moriya J; Fong GH; Sunagawa K; Shibuya M; Komuro I Circ Res; 2008 Aug; 103(3):261-8. PubMed ID: 18583712 [TBL] [Abstract][Full Text] [Related]
25. Sphingosine 1-phosphate induces EGFR expression via Akt/NF-kappaB and ERK/AP-1 pathways in rat vascular smooth muscle cells. Hsieh HL; Sun CC; Wu CB; Wu CY; Tung WH; Wang HH; Yang CM J Cell Biochem; 2008 Apr; 103(6):1732-46. PubMed ID: 17902169 [TBL] [Abstract][Full Text] [Related]
26. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. Hendriks-Balk MC; Hajji N; van Loenen PB; Michel MC; Peters SL; Alewijnse AE Eur J Pharmacol; 2009 Mar; 606(1-3):25-31. PubMed ID: 19374869 [TBL] [Abstract][Full Text] [Related]
27. FTY720 modulates human oligodendrocyte progenitor process extension and survival. Miron VE; Jung CG; Kim HJ; Kennedy TE; Soliven B; Antel JP Ann Neurol; 2008 Jan; 63(1):61-71. PubMed ID: 17918267 [TBL] [Abstract][Full Text] [Related]
28. Effects of sphingosine 1-phosphate on calcium signaling, proliferation and S1P2 receptor expression in PC Cl3 rat thyroid cells. Björklund S; Palmberg S; Rask S; Westerdahl AC; Törnquist K Mol Cell Endocrinol; 2005 Feb; 231(1-2):65-74. PubMed ID: 15713536 [TBL] [Abstract][Full Text] [Related]
29. VEGF-C promotes the development of esophageal cancer via regulating CNTN-1 expression. Liu P; Zhou J; Zhu H; Xie L; Wang F; Liu B; Shen W; Ye W; Xiang B; Zhu X; Shi R; Zhang S Cytokine; 2011 Jul; 55(1):8-17. PubMed ID: 21482472 [TBL] [Abstract][Full Text] [Related]
30. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms. Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837 [TBL] [Abstract][Full Text] [Related]
31. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer. Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086 [TBL] [Abstract][Full Text] [Related]
32. Differential regulation of vascular endothelial growth factor receptors (VEGFR) revealed by RNA interference: interactions of VEGFR-1 and VEGFR-2 in endothelial cell signaling. Kou R; SenBanerjee S; Jain MK; Michel T Biochemistry; 2005 Nov; 44(45):15064-73. PubMed ID: 16274253 [TBL] [Abstract][Full Text] [Related]
33. Selective attenuation of Toll-like receptor 2 signalling may explain the atheroprotective effect of sphingosine 1-phosphate. Dueñas AI; Aceves M; Fernández-Pisonero I; Gómez C; Orduña A; Crespo MS; García-Rodríguez C Cardiovasc Res; 2008 Aug; 79(3):537-44. PubMed ID: 18411230 [TBL] [Abstract][Full Text] [Related]
35. Sphingosine 1-phosphate receptor expression profile and regulation of migration in human thyroid cancer cells. Balthasar S; Samulin J; Ahlgren H; Bergelin N; Lundqvist M; Toescu EC; Eggo MC; Törnquist K Biochem J; 2006 Sep; 398(3):547-56. PubMed ID: 16753042 [TBL] [Abstract][Full Text] [Related]
36. Blocking S1P interaction with S1P₁ receptor by a novel competitive S1P₁-selective antagonist inhibits angiogenesis. Fujii Y; Ueda Y; Ohtake H; Ono N; Takayama T; Nakazawa K; Igarashi Y; Goitsuka R Biochem Biophys Res Commun; 2012 Mar; 419(4):754-60. PubMed ID: 22387544 [TBL] [Abstract][Full Text] [Related]
37. Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of epidermal growth factor receptor and vascular growth factor receptor phosphorylation. Younes MN; Yigitbasi OG; Park YW; Kim SJ; Jasser SA; Hawthorne VS; Yazici YD; Mandal M; Bekele BN; Bucana CD; Fidler IJ; Myers JN Cancer Res; 2005 Jun; 65(11):4716-27. PubMed ID: 15930290 [TBL] [Abstract][Full Text] [Related]
38. Regional effects of an antivascular endothelial growth factor receptor monoclonal antibody on receptor phosphorylation and apoptosis in human 253J B-V bladder cancer xenografts. Davis DW; Inoue K; Dinney CP; Hicklin DJ; Abbruzzese JL; McConkey DJ Cancer Res; 2004 Jul; 64(13):4601-10. PubMed ID: 15231672 [TBL] [Abstract][Full Text] [Related]